Introduction
Epstein-Barr virus (EBV) infection is prevalent in all human populations. Both B lymphocytes and epithelial cells can be infected and appear to be sites of virus latency and replication. The virus is capable of adopting three distinct programmes of latency (latency I, II and III) (Kerr et al., 1992) . In type III latency, six nuclear antigens (EBNA1-6) are expressed from a polycistronic transcription unit that is under the transcriptional control of either of two virus promoters, Cp and Wp (Bodescot et al., 1987) . The three members of the latent membrane protein family, LMP1, LMP2A and LMP2B, are also expressed (Hudson et al., 1985) . In types I and II latency, the expression of nuclear antigens is restricted to EBNA1 (Rowe et al., 1986) and Cp and Wp are quiescent (Rowe & Gregory, 1989) . Type Author for correspondence : Lars Rymo.
Fax j46 31 828458. e-mail lars.rymo!ss.gu.se II latency differs from type I latency only in the expression of variable combinations of LMP1, LMP2A and LMP2B in addition to EBNA1 (Kerr et al., 1992) . EBNA1 is the only EBV protein expressed in all known states of EBV latency and in the virus lytic cycle, and is required for the maintenance of the EBV episome (Kieff, 1996) .
EBNA1-specific initiation of transcription in cells in type I and II latency was thought for some time to occur at a promoter (Fp) in the BamHI F fragment (Nonkwelo et al., 1995 ; Sample et al., 1991 ; Schaefer et al., 1991) , but recent data suggest strongly that the dominant EBNA1 promoter in these cells (Qp) is located about 210 bp downstream of Fp in the BamHI Q fragment Tsai et al., 1995) . Fp is reported to have the characteristics of an early lytic promoter and the majority of Fp-initiated transcripts are not spliced to the EBNA1-encoding K exon at the splice acceptor site in BamHI K . One essential step in understanding the mechanisms responsible for EBNA1-re-stricted programmes of latency and the switch from a type III to a type I pattern of viral gene expression is to elucidate the relative activity of the different EBNA1 gene promoters during different stages of latency. Previous analyses of Qp-and Fpinitiated transcription in latency I-III B-cell lines have been based either on RT-PCR methods or on S1 nuclease and RNase protection assays with short probes that do not contain EBNA1-encoding sequences. This makes it difficult to assess the relative contribution of different promoters to EBNA1 transcription and in the latter case also involves a risk of detecting transcripts other than those that encode EBNA1. In the present work we have quantified the relative levels of differently spliced mRNAs that contained sequences from the open reading frame for EBNA1 (BKRF1) in various EBVtransformed cell lines and in cell lines induced to enter the lytic cycle. To this end, we have performed RNase protection assays on cytoplasmic RNA with RNA probes generated from EBNA1 cDNA clones that represented different 5h ends and splicing patterns, with the first 160 nt of the EBNA1-encoding K exon as a common factor. The results of the RNase protection assays were confirmed by qualitative RT-PCR.
Methods
Cell lines. The cell lines used in this study and their phenotypic characteristics are listed in Tables 2 and 3 . All cell lines were propagated in RPMI 1640 (Life Technologies) supplemented with 10 % foetal calf serum (Life Technologies), penicillin and streptomycin. Induction of the virus lytic cycle in B95-8 and P3HR-1 was performed by the addition of 12-O-tetradecanoylphorbol 13-acetate (TPA ; Sigma) to a concentration of 21 ng\ml (Hudewentz et al., 1980) . Induction of the virus lytic cycle in Rael was performed by the addition of 5-azacytidine to a concentration of 5 µM (Masucci et al., 1989) . Cells were harvested after 48 h. Induction of the lytic cycle was confirmed by detection of the EBV lytic cycle protein Zebra in Western blots with the polyclonal human serum CW.
Preparation of RNA. Cytoplasmic RNA was prepared by the sucrose cushion method of Favaloro et al. (1980) with 10 mM vanadylribonucleoside complexes as RNase inhibitors, treated with RQ1 DNase (Promega) and stored at k70 mC.
Plasmid construction. Plasmids for the generation of riboprobes A, B and C (Fig. 1) were constructed by cloning of PCR-amplified fragments of B95-8 EBNA1 cDNA in TA-vectors (Invitrogen). Primers used in cDNA synthesis and PCR are described in Table 1 . Briefly, B95-8 EBV cDNA was generated according to the method of Kawasaki (1990) by reverse transcription of cytoplasmic RNA with 10 pmol primer K1 in 50 mM Tris-HCl (pH 8n3), 75 mM KCl, 3 mM MgCl # , 10 mM dithiothreitol, 0n5 mM of each nucleotide and 200 units SuperScript II RNase H reverse transcriptase (Life Technologies) for 50 min at 42 mC in a total volume of 20 µl. The mixture was then heated for 15 min at 70 mC, cooled and stored at k20 mC. Aliquots of the cDNA were amplified by PCR with 10 pmol each of primers Q2 and K2. The thermocycling parameters used for all primer pairs were as follows : initial denaturation for 30 s at 94 mC followed by 35 cycles of 30 s at 94 mC, 30 s at 55-60 mC and 30 s at 72 mC. Two DNA fragments, of 358 and 186 bp, were obtained and shown by sequencing to contain the QUK and QK exons, respectively. The Q\K splice has not been described before (A. Ricksten, unpublished data) . The QUK and QK fragments were expanded by PCR Open boxes indicate sequences from the exons of the different EBNA1-specific transcripts and lines indicate sequences from the plasmids from which the probes were synthesized. Numbers in parentheses indicate the numbers of nucleotides in exons and plasmid-derived sequences. The riboprobes do not detect Cp/Wp-initiated transcripts directly : protection of the part of the probes corresponding to UK was taken to represent Cp/Wp-initiated transcripts but only in cases where such transcripts could also be identified by RT-PCR. to include sequences immediately upstream of Qp to position 62399 in the EBV genome. Plasmids for the generation of riboprobes A and C were constructed by joining a segment of the FQ region of B95-8 EBV DNA (coordinates 62122-62448) to the elongated QUK and QK fragments followed by subcloning into the pCR 2.1 vector (Invitrogen) ; the plasmids were designated p∆FQUK and p∆FQK. For riboprobe B, the elongated QUK fragment was subcloned into the pCR II vector (Invitrogen) ; the plasmid was designated p∆QUK. Riboprobe D (Fig. 1 ) was generated to confirm the data obtained from RNase protection analysis with riboprobe B. A plasmid was constructed by PCR amplification of a 337 bp fragment from p∆QUK with the ExoClone PCR-cloning kit (Sigma). The fragment was subcloned into the EcoRI site in the pGEM-3Zf(j) vector (Promega) and the plasmid was designated p∆QUK "!& . A plasmid for the synthesis of riboprobe E (Fig. 4 a) was constructed by PCR amplification and subcloning of a BamHI K fragment (position 107565-108102 in the EBV genome) from the EBNA1 expression vector pBK2 (Nilsson et al., 1993) into the HindIII and XbaI sites in the pGEM-3Zf(j) vector (Promega). The plasmid was designated p∆K. All constructs were verified by dideoxy sequencing (Sanger et al., 1977) using the Sequenase system (USB). p∆FQUK contained a point mutation at position 67531 in exon U as compared to B95-8 EBV DNA.
RT-PCR.
Oligonucleotides used for cDNA synthesis, PCR and hybridization are listed in Table 1 and depicted in Fig. 2 . RT-PCR analysis of EBNA1 mRNA was performed according to the procedure described above and with the primer combinations indicated in Table 3 . The PCR products were characterized by electrophoresis in agarose gels and hybridization to U-and K-specific biotinylated probes in two separate Southern blots (Sambrook et al., 1989) . Hybridization signals were detected by using streptavidin-conjugated peroxidase (Boehringer Mannheim) and the ECL system (Amersham).
RNase protection assay. For the synthesis of $#P-labelled RNA as hybridization probes, plasmid DNA was transcribed in vitro in the presence of [α-$#P]CTP (3000 Ci\mmol ; DuPont NEN) by a standard procedure (Sambrook et al., 1989) . Full-length RNA molecules were purified by PAGE and used as probes in the RNase protection assay (Ricksten et al., 1988) with the following modifications : 50 µg DNasetreated cytoplasmic RNA was mixed with $#P-labelled RNA (1i10' c.p.m.) and incubated at 50 mC for 16 h. Single-stranded material was hydrolysed by the addition of 300 µl digestion mixture (10 µg\ml RNase A, 16 U\ml RNase T1, 0n30 M sodium acetate, pH 7n0, 5n0 mM EDTA) and incubation at 37 mC for 60 min. The protected fragments were separated by electrophoresis in 4 % denaturing polyacrylamide gels and quantified by determining their radioactivity with a phosphorimager (Molecular Dynamics). To compare the intensities of the fragments on a molar basis the radioactivity measured for each band was divided by the number of C nucleotides calculated in the fragment. The C-normalized values for the K-containing fragments in the lanes corresponding to riboprobe B were summed and the relative amount of each fragment was calculated (Table 2) .
Results

B-lymphoid cells in latency I use predominantly Qp for EBNA1 transcription
To determine the relative levels of the different BKRF1 sequence-containing transcripts in latency I B cells, RNase protection assays of cytoplasmic RNA from cell lines Rael and Cheptage were performed with riboprobes A, B and C (Fig. 1) . A dominant protected fragment was detected with riboprobes A and B in Rael and Cheptage ( Fig. 3 and Table 2 ). The fragment had a size of 367 nt in both lanes and thus corresponded to a transcript initiated at Qp and spliced to the U and K exons ; the fragment was designated QpUK(367). There were also weak signals from a protected fragment with a size of 332 nt in both lanes. This corresponded well to a Uand K-containing transcript that lacked the Q exon, UK(332). Furthermore, there was a weak band with a size of 160 nt, corresponding to a transcript that only protected the part of the probes derived from the K exon ; this fragment was designated K(160). Since the RNA probes were labelled uniformly and contained the same 160 nt sequence complementary to the first part of the K exon, it was necessary to establish that the 332 and 160 nt fragments actually represented protection of the part of the probes derived from the K exon. For this purpose, riboprobe D was constructed, which was identical to riboprobe B except that the last 55 of the 160 nt corresponding to the part of the B probe derived from BKRF1 were deleted (Fig. 1 c) . RNase protection assays showed that the UK(332) and K(160) fragments generated with riboprobe B were transformed into fragments 55 nt shorter with the control probe, D, confirming that the probes were protected in the part that contained the BamHI K sequence (data not shown). The relative molar amounts of 6 c.p.m. of riboprobe A (lanes 1), B (lanes 2) or C (lanes 3) were hybridized and digested with RNase according to Methods. Protected fragments were analysed on a 4 % denaturing polyacrylamide gel. FpQUK(557) (lanes 1) corresponds to an Fp-initiated EBNA1 transcript. This was confirmed by the presence of QUK(392) (lanes 2), which represents the fully protected riboprobe B except the sequences from the plasmid from which the probe was synthesized (98 nt). FpQU(397) (lanes 1) represents an Fp-initiated lytic transcript that is not spliced to the common splice acceptor for the EBNA1-encoding K exon. The identity of this fragment was confirmed by the presence of QU(232) in lanes 2. QpUK(367) (lanes 1 and 2) corresponds to a Qp-initiated EBNA1 transcript. UK(332) (lanes 1 and 2) represents a Cp/Wp-initiated EBNA1 transcript. mm(270) (lanes 1) indicates a protected fragment that was the result of a point mutation in riboprobe A. FpQ(225) (lanes 1) represents an Fp-initiated lytic transcript that contains the Q but not the U exon. Q(60) (lanes 2) corresponds to this lytic FpQ transcript that only protects the part of riboprobe B derived from the Q exon. FpQ(225) in lanes 3 correlates with both FpQ-and FpQ/U-spliced transcripts, since riboprobe C does not contain the U exon. U(172) (lanes 1 and 2) probably reflects transcription of EBNA3, EBNA4 and EBNA6. K(160) (lanes 1 and 2) corresponds to all K-containing transcripts that do not use the U/K splice. K(160) in lanes 3 corresponds to all K-containing transcripts that do not use the Q/K splice, for which riboprobe C was constructed.
QpUK(367), UK(332) and K(160) were calculated from measurements of the radioactivity of the protected fragments in the lane of riboprobe B. QpUK(367) constituted 72-83 % of the total of the QpUK(367), UK(332) and K(160) fragments, and UK(332) and K(160) constituted 5n1-10 % and 11-18 %, respectively ( Table 2 ). The assumed exon composition of QpUK(367) was corroborated with RT-PCR analysis of RNA from Rael and Cheptage (Table 3) . RT-PCR with the combination of the primers Q2 and K2 resulted in an amplification product of the expected length that hybridized to the U and K probes. This indicated the presence of a transcript that spanned the QUK region. A negative PCR result was obtained with primers Q1 and K2, which confirmed the conclusion drawn from the RNase protection analyses that Fp 
is not significantly active in the Rael and Cheptage cell lines.
RT-PCR analysis with the Y3 and K2 primers gave negative results, indicating that the protected fragments UK(332) and K(160) did not originate from EBNA1-specific mRNAs with the standard splicing pattern of transcripts initiated at Cp\Wp.
B-lymphoid cells in latency II-III use Cp/Wp but also Qp for EBNA1 transcription
RNase protection analysis of cytoplasmic RNA from the latency II-III B-cell lines P3HR-1 and Raji demonstrated a different pattern of EBNA1 transcription compared to the latency I B cells (Fig. 3 and Table 2 ). QpUK(367) constituted 1-2 %, UK(332) 67-79 % and K(160) 18-33 % of the Kcontaining fragments. No fragments corresponding to Fpinitiated, K-containing transcripts were detected. RT-PCR analysis of RNA from Raji cells with the Y3 and K2 primers, specific for Cp\Wp-initiated EBNA1 transcripts, resulted in an amplification product that hybridized with the U and K probes (Table 3) . P3HR-1 RNA did not give an amplification product with these primers, because of the deletion in the BamHI Y-H region of the genome. Both cell lines generated an RT-PCR product with primers Q2 and K2 that hybridized with the U and K probes, confirming the presence of EBNA1-specific Qp activity in the P3HR-1 and Raji cell lines, in addition to the dominant Cp\Wp activity, as shown by RNase protection analysis. RT-PCR with the Fp-specific primers Q1 and K2 generated an amplification product in P3HR-1 but not in Raji, indicating low levels of Fp activity for EBNA1 gene tran- 
B-lymphoid cells in latency III use Cp/Wp but not Qp for EBNA1 transcription
RNase protection analysis of RNA from the latency III Bcell lines Mutu III, Namalva, CBC-Rael, WW1-LCL, B95-8 and IB4 demonstrated a uniform pattern of protected fragments compatible with the dominant usage of Cp\Wp for EBNA1 transcription (Fig. 3 and Table 2 ). Qp-derived fragments were not detected. UK(332) constituted 66-84 % and K(160) 15-34 % of the protected fragments. In B95-8 and CBC-Rael, weak signals of Fp activity were detected through the presence of the protected FpQUK(557) fragment. RT-PCR with primers Y3 and K2 resulted in an amplification product that hybridized with the U and K probes in all latency III B cells (Table 3) . This supports the notion that in this case, the dominant protected fragment in the RNase protection assays, UK(332), represented an EBNA1 transcript initiated at Cp\Wp. RT-PCR analysis of B95-8 and CBC-Rael cells resulted in amplification products containing U and K sequences with both the Q2 and K2 and Q1 and K2 primer combinations. We interpret this last series of amplifications to reflect the low levels of Fp-initiated, Kcontaining transcripts observed in B95-8 and CBC-Rael cells in the RNase protection assays.
Fp activity is up-regulated upon induction of the virus lytic cycle
Induction of Rael cells by the demethylating agent 5-azacytidine and induction of B95-8 and P3HR-1 cells by TPA resulted in fragment patterns in RNase protection and RT-PCR analysis that corresponded to up-regulation of Fp activity ( Fig.  3 and Table 3 ). FpQUK(557) constituted 1-6 % of the Kcontaining transcripts in induced cell lines (Table 2) . RT-PCR with primers Q1 and K2 generated an amplification product that hybridized to the U and K probes, reflecting this small proportion of Fp-initiated transcripts spliced to the EBNA1-specific splice acceptor site in BamHI K. Induction of Rael cells with 5-azacytidine is known to up-regulate Cp\Wp-initiated transcription (Altiok et al., 1992 ; Jansson et al., 1992) , shown here by the increased amounts of the protected UK(332) and U(172) fragments and the appearance of a specific amplification transcript that is initiated upstream of the BamHI f/K cleavage site, passing through BamHI K directly into the EBNA1-encoding K exon. The K(350-370) fragments represent transcripts that contain the part of BamHI K upstream of the splice acceptor site for BKRF1, most likely corresponding to a lytic BRRF2 transcript. K(160) corresponds to all BKRF1-containing transcripts that use the regular splice acceptor site for the EBNA1-encoding exon. (c) RT-PCR analysis of RNA from the cell lines used in Fig.  4(b) . After reverse transcription with the K1 primer and PCR amplification with the primers K3 (located upstream of the EBNA1 splice acceptor in BamHI K) and K2, a specific product of 350 bp was detected by Southern blotting with the K probe, confirming the data presented in Fig. 4 (b) (lanes 1-9) . To detect DNA contamination of the RNA preparations, 1 µg RNA from the cell lines in lanes 4 and 7-9 was PCR-amplified with primers K2 and K3 without reverse transcription (lanes 11-14) . DNA contamination was detected in TPA-induced P3HR-1. The EBNA1 expression vector pBK2 was used as a positive control (lane 15).
product with primers Y3 and K2 in the RNase protection and PCR analysis (Fig. 3 and Tables 2 and 3 ). The protected fragment U(172) presumably represented up-regulation of Cp\Wp-initiated transcription of the EBNA3, 4 and 6 genes. Induction of P3HR-1 and B95-8 cells produced essentially similar results, except that there were no signs of Qp activity in induced B95-8 cells. It should be noted that the majority of the Fp-initiated transcripts detected did not contain the U\K splice. The protected FpQUK(557) fragment, which represented Fp-initiated, U\K-spliced transcripts, only constituted 1n4 % of the sum of FpQUK (557), FpQU(397) and FpQ(225) in induced Rael and 1n6 % in induced B95-8 cells. The protected FpQU(397) fragment, which might correspond to the lytic FpQ\U-spliced transcript of undefined intron\exon composition at its 3h end that has been previously reported , constituted 24 % of the Fp-initiated transcripts in induced Rael cells and 47 % in induced B95-8 cells but was not detectable in growing Rael cells and gave a very weak band in growing B95-8 cells. A fragment with a size of 225 nt was detected with riboprobe A in RNase protection assays of RNA from induced Rael, P3HR-1 and B95-8 cells. This fragment was compatible with an FpQ-containing transcript that was not spliced to the U exon. It was designated FpQ (225) and confirmed by the detection of Q(60) with riboprobe B. It constituted as much as 75 % of the sum of the Fp-initiated transcripts in induced Rael cells and 52 % in induced B95-8 cells but was not detectable or was present at very low levels in growing cells.
A new BKRF1 sequence-containing RNA is induced in lytic infection
A varying but significant amount of K(160), a protected fragment corresponding to the parts of riboprobes A and B derived from BamHI K, was found in RNA from all the cell lines examined. In order to answer the question of whether K(160) was derived from transcripts that used the common EBNA1 splice acceptor site in BamHI K or from transcripts that, in addition to the EBNA1-encoding K exon, contained K sequences upstream of this splice site, we performed RNase protection analysis with riboprobe E (Fig. 4) . All latent cell lines investigated so far have been shown to use this splice site. However, a protected fragment with a size of 534 nt, corresponding to the full length of the part of the probe derived from BamHI K, was detected in B95-8 cells and in cells induced to enter the virus lytic cycle. The B95-8 cell line is known to contain lytic subpopulations. This fragment indicated the presence of a lytic RNA initiated 5h of the BamHI f\K cleavage site and continuing through BamHI K into BKRF1 without interruption. The transcript constituted 4 % of BKRF1 sequence-containing RNAs in B95-8 cells and 29 % after induction of the lytic cycle. The transcript was below the detection level in Rael and P3HR-1 cells but increased to relative levels of 11 % and 48 %, respectively, after induction of the lytic cycle. In addition, the RNase protection assays revealed the presence of protected fragments ranging in size from 350 to 370 nt, K(350-370). RNase protection assays with a modified probe E that contained a shorter part of BKRF1 demonstrated that these fragments were derived from transcripts initiated 5h of the BamHI f\K cleavage site and terminated before BKRF1 (data not shown). Most likely, the K(350-370) fragments were derived from a lytic BRRF2 transcript (Mellinghoff et al., 1991) . To confirm further the identification of a transcript that contained BamHI K sequences 5h of and including BKRF1, RT-PCR was performed with primers K2 and K3 (Fig. 4 c) .
Low levels of a Q/K-spliced transcript in latency III Bcell lines
A splice joining the Q and K exons was detected in cytoplasmic RNA extracted from cervical carcinoma biopsies and B95-8 cells by RT-PCR with primers Q2 and K1 and the nested primers Q3 and K2 (A. Ricksten, unpublished data). Riboprobe C, specific for this splice, was included in this study to determine whether Q\K-spliced transcripts were present in EBV-transformed B-lymphoid cell lines. The RNase protection analyses did not indicate the presence of significant levels of mRNA with this splice in any of the latency I, II-III or III B-cell phenotypes (Fig. 3) . However, RT-PCR analysis of RNA from the latency III B cell lines Mutu III, CBC-Rael and B95-8 and from induced P3HR-1 and B95-8 cells, with primers Q2 and K1 and the nested primers Q3 and K2, generated a weak band corresponding to a product of 186 bp (data not shown). This is compatible with the presence of low levels of a Q\K-spliced transcript in these cells.
Discussion
The differential use of promoters for transcription of the EBNA1 gene has been the subject of several investigations but the molecular mechanism underlying the switches between the promoters is still not understood. As a part of a study of this question, we have determined the relative levels of differently spliced BKRF1-containing transcripts in various EBV-transformed cell lines by using RNase protection assays. Our results confirm and extend previous reports of the dominance of Qp in latency I B cells and Cp\Wp in latency II-III and III B cells for the initiation of EBNA1 transcription. However, all cell lines examined exhibited a substantial fraction of BKRF1-containing transcripts that differed from known Cp\Wp-and Qp-initiated EBNA1 transcripts. This suggests the possibility of an additional promoter(s) for EBNA1 gene transcription or alternative splicing patterns. We also present data on a previously undescribed lytic BKRF1-containing mRNA that does not use the regular EBNA1 splice acceptor site in BamHI K.
Our RNase protection analysis of EBNA1 gene transcription resulted in a fragment pattern that indicated the predominance of a Qp\U\K-spliced mRNA in latency I B cells. However, significant amounts of other fragments, UK(332) and K(160), the presence of which could not easily be explained by this transcript, were also detected. The UK(332) fragment is usually the product of EBNA1 transcripts initiated at Cp\Wp, which in latency I cells would suggest ' leakiness ' towards a latency III expression pattern. Arguing against this interpretation is the consistently negative outcome of Cp\Wp-specific PCR analysis with primers Y3 and K2 and the absence of an RNase-protected U fragment, U(172), indicative of Cp\Wp-initiated transcription of the EBNA3, 4 and 6 genes. A possible source of the protected UK(332) fragment in latency I cells could be a Qp-initiated transcript with a 5h end intron\exon composition different from the standard Qp\U\K-spliced EBNA1 mRNA, as a result of alternative splicing or incomplete processing. Incomplete processing of the Qp\U intron would result in an RT-PCR amplification product about 3n7 kbp longer than the corresponding standard fragment, which presumably would not be detected under our assay conditions. In fact, only a single PCR amplification product of a length compatible with the standard Qp\U\K-spliced mRNA was obtained with primers specific for Qp-initiated transcripts. However, alternative splicing coupled with small or compensatory differences in the location of the splice donor and acceptor sites for the Qp\U intron might result in a PCR product inseparable from the standard fragment. At present, we consider this to be the most probable explanation for the UK(332) fragment, although we cannot exclude the possibility of a previously unidentified initiation site for the corresponding transcript.
By a similar line of argument, the RNase-protected K(160) fragment obtained from cytoplasmic RNA from latency I B cells corresponds to a BKRF1 sequence-containing transcript with a 5h end structure different from the standard Qp-initiated Qp\U\K EBNA1 mRNA, and which is not detected by PCR with primers specific for initiation at Cp\Wp, Qp or Fp. In this case, a partially processed standard transcript (Qp\U-intron-K) would be unlikely to produce a detectable product under the conditions of our RT-PCR analysis, due to the length of the intron. We have no indication of Q\K-spliced transcripts in latency I B cells. In addition, our results demonstrated that the K(160) fragment was accounted for by mRNAs that used the common EBNA1 splice acceptor site in BamHI K and that BamHI K sequences directly upstream of this site were not included in the transcript (Fig. 4) . Taken together, the UK(332) and K(160) results suggest that more than one EBNA1-coding mRNA species may exist in latency I B cells. Additional evidence for such a notion comes from reports of the presence of two discrete EBNA1 mRNAs about 2n5 and 5 kb in length in the type I latent B-cell lines Akata and Rael (Schaefer et al., 1991 .
Latency II-III and latency III B cells predominantly use Cp and Wp for EBNA1 gene transcription but the cells also contained significant amounts of transcripts that generated the protected K(160) fragment with the A and B riboprobes. In latency III cells, this fragment might be derived from an RNA corresponding to the Wp\Y1\Y2\U\E\K-spliced transcript described in the lymphoblastoid cell line JY (Speck & Strominger, 1985) . Since this mRNA lacks the Y3 exon, it would not be detected by our RT-PCR analysis with primers Y3 and K2. However, RT-PCR analysis of RNA from P3HR-1, CBC-Rael and B95-8 with primer Y2 combined with K2 resulted only in products compatible with Y2\Y3\U\K-spliced transcripts that did not contain the 370 nt E exon (data not shown). Low levels of a Q\K-spliced transcript were detected in some latency III cell lines by nested PCR but not by the RNase protection assays. Thus, K(160) did not originate from Q\K-spliced transcripts. Both Cp\Wp and Qp were used in the latency II-III Raji and P3HR-1 cells, although the level of Qp-initiated transcripts was considerably lower. Nonkwelo et al. (1997) have proposed that Cp\Wp and Qp usage is mutually exclusive, due to down-regulation of Qp by the high levels of EBNA1 in Cp\Wp-using cells. A possible explanation of our observation would be that the level of EBNA1 in the latency II-III cells in general is lower than in latency III cells in some cases, allowing a certain level of Qp activity.
The BamHI F promoter is activated in EBV-transformed B cells on entry into the lytic cycle. From the data obtained by and , it appears that a small fraction of Fp-initiated lytic transcripts splice from the U exon to the EBNA1-coding exon (FpQ\U\K-splicing pattern). In this report, we show that only about 1n5 % of Fp-initiated transcripts in the cell lines induced to enter the lytic cycle that we examined exhibited this FpQ\U\K-splicing pattern. FpQ\U-spliced transcripts that did not use the common EBNA1 splice acceptor site in BamHI K made up 24-47 % of the transcripts and as much as 52-75 % were Fp-initiated transcripts that contained the Q exon but not the regular Q\U splice. The level of FpQ\U\K-spliced transcripts relative to all BKRF1-containing transcripts was only 1-6 % in induced cell lines (Table 2) . It should be noted that EBNA1 is the only EBNA that continues to be synthesized when cells are induced to enter the lytic cycle Weigel et al., 1985) . Cp\Wp activity is down-regulated in lytic infection and the Fp promoter is activated . Our results suggest that the level of FpQ\U\K-spliced transcripts is too low to represent the principal source of EBNA1-specific mRNA in lytic infection, and that the majority of Fp-initiated transcripts Fig. 5 . Schematic illustration of three proposed alternative structures of a lytic cycle-specific EBNA1 mRNA. Thin horizontal lines indicate exons, denoted by letters. Dotted lines indicate uncharacterized sequences and splice sites. The FQ exon has been described previously (Sample et al., 1991 ; Schaefer et al., 1991) . The FQh and Uh exons either extend past the regular splice donor sites in Q and U, respectively, for undetermined distances or use splice acceptors that are not detected with the RNA probes employed in this study. The distances between exons are not drawn to scale. We suggest that there may be a relationship between FpQ/Uh and/or FpQh and the lytic BKRF1-containing mRNA described in this paper. Alternatively, EBNA1 gene transcription in the lytic cycle might be initiated at an as yet unidentified lytic promoter (alternative 3).
in the induced cells is not spliced to the common EBNA1 splice acceptor in BamHI K. Furthermore, we have identified a previously undescribed BKRF1 sequence-containing transcript present at significant levels in lytically induced cells. The transcript contains the BamHI K sequences 5h of and including BKRF1 but it does not use the common EBNA1 splice acceptor site in BamHI K. We suggest that this RNA is the product of a specific transcription unit serving the purpose of maintaining EBNA1 expression in the virus lytic cycle. Evidence corroborating the existence of an RNA species with the properties described above was found in a study of the relation between the level of Fp-initiated transcripts and K-containing transcripts in cell lines induced to enter the lytic cycle, as determined by S1 nuclease analysis . The K probe employed in these analyses spanned the splice acceptor site for BKRF1 and included 17 nt at its 3h end from the BamHI K sequence upstream of the splice acceptor site. The results showed a marked increase in Fp activity but an essentially unaltered level of transcripts that used the K splice acceptor site after induction of the lytic cycle. However, the published figures also indicated increased levels of a transcript that gave complete protection of the probe. This RNA might correspond to the BKRF1 sequence-containing mRNA described in the present paper that is induced in the lytic cycle and does not use the common EBNA1 splice acceptor site. In the same work by , Northern blot analysis of lytic FQ exoncontaining transcripts identified two large transcripts of about 9 and 15 kb. We suggest that there might be a relation between the FpQ-and FpQ\U-spliced transcripts of presently undefined 3h end exon composition and the lytic cycle-specific, BKRF1-containing mRNA described in this paper (Fig. 5) . The 9-15 kb transcripts would not be detected under the PCR conditions employed in this study. Alternatively, the lytic EBNA1 mRNA might be generated by transcription initiated at an as yet unidentified lytic promoter.
